{"id":"https://openalex.org/W2158971458","doi":"https://doi.org/10.1158/1535-7163.mct-09-0300","title":"Combination of EGFR and MEK1/2 inhibitor shows synergistic effects by suppressing EGFR/HER3-dependent AKT activation in human gastric cancer cells","display_name":"Combination of EGFR and MEK1/2 inhibitor shows synergistic effects by suppressing EGFR/HER3-dependent AKT activation in human gastric cancer cells","alternate_titles":[],"publication_year":2009,"publication_date":"2009-09-01","ids":{"openalex":"https://openalex.org/W2158971458","doi":"https://doi.org/10.1158/1535-7163.mct-09-0300","mag":"2158971458","pmid":"https://pubmed.ncbi.nlm.nih.gov/19755509"},"language":"en","primary_location":{"id":"doi:10.1158/1535-7163.mct-09-0300","doi":"https://doi.org/10.1158/1535-7163.mct-09-0300","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1535-7163.mct-09-0300","pdf_url":null,"source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2158971458"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5036241941","display_name":"Young\u2010Kwang Yoon","orcid":"https://orcid.org/0000-0002-7357-5724","observed_orcids":["https://orcid.org/0000-0002-7357-5724"]},"institutions":[{"id":"https://openalex.org/I139264467","display_name":"Seoul National University","ror":"https://ror.org/04h9pn542","country_code":"KR","type":"education","lineage":["https://openalex.org/I139264467"]}],"countries":["KR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Young-Kwang Yoon","raw_affiliation_strings":["1Cancer Research Institute, 2Department of Internal Medicine, College of Medicine, and 3Department of Molecular Medicine and Biopharmaceutical Science, Graduate School of Convergence Science and Technology, Seoul National University, Seoul, Korea"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Cancer Research Institute, 2Department of Internal Medicine, College of Medicine, and 3Department of Molecular Medicine and Biopharmaceutical Science, Graduate School of Convergence Science and Technology, Seoul National University, Seoul, Korea","institution_ids":["https://openalex.org/I139264467"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110967211","display_name":"Hwang\u2010Phill Kim","orcid":"https://orcid.org/0000-0002-7423-9044","observed_orcids":["https://orcid.org/0000-0002-7423-9044"]},"institutions":[{"id":"https://openalex.org/I139264467","display_name":"Seoul National University","ror":"https://ror.org/04h9pn542","country_code":"KR","type":"education","lineage":["https://openalex.org/I139264467"]}],"countries":["KR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Hwang-Phill Kim","raw_affiliation_strings":["1Cancer Research Institute, 2Department of Internal Medicine, College of Medicine, and 3Department of Molecular Medicine and Biopharmaceutical Science, Graduate School of Convergence Science and Technology, Seoul National University, Seoul, Korea"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Cancer Research Institute, 2Department of Internal Medicine, College of Medicine, and 3Department of Molecular Medicine and Biopharmaceutical Science, Graduate School of Convergence Science and Technology, Seoul National University, Seoul, Korea","institution_ids":["https://openalex.org/I139264467"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052823826","display_name":"Sae\u2010Won Han","orcid":"https://orcid.org/0000-0003-3275-431X","observed_orcids":["https://orcid.org/0000-0003-3275-431X"]},"institutions":[{"id":"https://openalex.org/I139264467","display_name":"Seoul National University","ror":"https://ror.org/04h9pn542","country_code":"KR","type":"education","lineage":["https://openalex.org/I139264467"]}],"countries":["KR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Sae-Won Han","raw_affiliation_strings":["1Cancer Research Institute, 2Department of Internal Medicine, College of Medicine, and 3Department of Molecular Medicine and Biopharmaceutical Science, Graduate School of Convergence Science and Technology, Seoul National University, Seoul, Korea"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Cancer Research Institute, 2Department of Internal Medicine, College of Medicine, and 3Department of Molecular Medicine and Biopharmaceutical Science, Graduate School of Convergence Science and Technology, Seoul National University, Seoul, Korea","institution_ids":["https://openalex.org/I139264467"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108833850","display_name":"Hyung-Seok Hur","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I139264467","display_name":"Seoul National University","ror":"https://ror.org/04h9pn542","country_code":"KR","type":"education","lineage":["https://openalex.org/I139264467"]}],"countries":["KR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Hyung-Seok Hur","raw_affiliation_strings":["1Cancer Research Institute, 2Department of Internal Medicine, College of Medicine, and 3Department of Molecular Medicine and Biopharmaceutical Science, Graduate School of Convergence Science and Technology, Seoul National University, Seoul, Korea"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Cancer Research Institute, 2Department of Internal Medicine, College of Medicine, and 3Department of Molecular Medicine and Biopharmaceutical Science, Graduate School of Convergence Science and Technology, Seoul National University, Seoul, Korea","institution_ids":["https://openalex.org/I139264467"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112268597","display_name":"Do Youn Oh","orcid":"https://orcid.org/0000-0003-1663-9901","observed_orcids":["https://orcid.org/0000-0003-1663-9901"]},"institutions":[{"id":"https://openalex.org/I139264467","display_name":"Seoul National University","ror":"https://ror.org/04h9pn542","country_code":"KR","type":"education","lineage":["https://openalex.org/I139264467"]}],"countries":["KR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Do Youn Oh","raw_affiliation_strings":["1Cancer Research Institute, 2Department of Internal Medicine, College of Medicine, and 3Department of Molecular Medicine and Biopharmaceutical Science, Graduate School of Convergence Science and Technology, Seoul National University, Seoul, Korea"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Cancer Research Institute, 2Department of Internal Medicine, College of Medicine, and 3Department of Molecular Medicine and Biopharmaceutical Science, Graduate School of Convergence Science and Technology, Seoul National University, Seoul, Korea","institution_ids":["https://openalex.org/I139264467"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069050806","display_name":"Seock\u2010Ah Im","orcid":"https://orcid.org/0000-0002-5396-6533","observed_orcids":["https://orcid.org/0000-0002-5396-6533"]},"institutions":[{"id":"https://openalex.org/I139264467","display_name":"Seoul National University","ror":"https://ror.org/04h9pn542","country_code":"KR","type":"education","lineage":["https://openalex.org/I139264467"]}],"countries":["KR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Seock-Ah Im","raw_affiliation_strings":["1Cancer Research Institute, 2Department of Internal Medicine, College of Medicine, and 3Department of Molecular Medicine and Biopharmaceutical Science, Graduate School of Convergence Science and Technology, Seoul National University, Seoul, Korea"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Cancer Research Institute, 2Department of Internal Medicine, College of Medicine, and 3Department of Molecular Medicine and Biopharmaceutical Science, Graduate School of Convergence Science and Technology, Seoul National University, Seoul, Korea","institution_ids":["https://openalex.org/I139264467"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050684671","display_name":"Yung\u2010Jue Bang","orcid":"https://orcid.org/0000-0001-6000-4597","observed_orcids":["https://orcid.org/0000-0001-6000-4597"]},"institutions":[{"id":"https://openalex.org/I139264467","display_name":"Seoul National University","ror":"https://ror.org/04h9pn542","country_code":"KR","type":"education","lineage":["https://openalex.org/I139264467"]}],"countries":["KR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Yung-Jue Bang","raw_affiliation_strings":["1Cancer Research Institute, 2Department of Internal Medicine, College of Medicine, and 3Department of Molecular Medicine and Biopharmaceutical Science, Graduate School of Convergence Science and Technology, Seoul National University, Seoul, Korea"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Cancer Research Institute, 2Department of Internal Medicine, College of Medicine, and 3Department of Molecular Medicine and Biopharmaceutical Science, Graduate School of Convergence Science and Technology, Seoul National University, Seoul, Korea","institution_ids":["https://openalex.org/I139264467"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5114045534","display_name":"Tae\u2010You Kim","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I139264467","display_name":"Seoul National University","ror":"https://ror.org/04h9pn542","country_code":"KR","type":"education","lineage":["https://openalex.org/I139264467"]}],"countries":["KR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Tae-You Kim","raw_affiliation_strings":["1Cancer Research Institute, 2Department of Internal Medicine, College of Medicine, and 3Department of Molecular Medicine and Biopharmaceutical Science, Graduate School of Convergence Science and Technology, Seoul National University, Seoul, Korea"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Cancer Research Institute, 2Department of Internal Medicine, College of Medicine, and 3Department of Molecular Medicine and Biopharmaceutical Science, Graduate School of Convergence Science and Technology, Seoul National University, Seoul, Korea","institution_ids":["https://openalex.org/I139264467"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I139264467"],"apc_list":null,"apc_paid":null,"fwci":2.5421,"has_fulltext":false,"cited_by_count":77,"citation_normalized_percentile":{"value":0.90081691,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":99},"biblio":{"volume":"8","issue":"9","first_page":"2526","last_page":"2536"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.32179999351501465,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.32179999351501465,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.3086000084877014,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.19449999928474426,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/egfr-tyrosine-kinase-inhibitors","display_name":"EGFR tyrosine kinase inhibitors","score":0.8769999742507935},{"id":"https://openalex.org/keywords/mek-inhibitors","display_name":"MEK inhibitors","score":0.878000020980835},{"id":"https://openalex.org/keywords/gastric-cancer","display_name":"gastric cancer","score":0.722000002861023},{"id":"https://openalex.org/keywords/her3","display_name":"HER3","score":0.6700000166893005},{"id":"https://openalex.org/keywords/akt-activation","display_name":"Akt activation","score":0.9739999771118164},{"id":"https://openalex.org/keywords/pi3k-signaling","display_name":"PI3K signaling","score":0.8029999732971191},{"id":"https://openalex.org/keywords/kras-mutation","display_name":"KRAS mutation","score":0.8159999847412109},{"id":"https://openalex.org/keywords/drug-synergy","display_name":"drug synergy","score":0.6819999814033508},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.5699999928474426},{"id":"https://openalex.org/keywords/selumetinib","display_name":"selumetinib","score":0.8389999866485596},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.6690000295639038},{"id":"https://openalex.org/keywords/pathway-crosstalk","display_name":"pathway crosstalk","score":0.574999988079071}],"concepts":[{"id":"https://openalex.org/C2781187634","wikidata":"https://www.wikidata.org/wiki/Q20969980","display_name":"KRAS","level":4,"score":0.8456571102142334},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.7170478105545044},{"id":"https://openalex.org/C2777506169","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"EGFR inhibitors","level":4,"score":0.6153255701065063},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5865616798400879},{"id":"https://openalex.org/C75217442","wikidata":"https://www.wikidata.org/wiki/Q423650","display_name":"Protein kinase B","level":3,"score":0.5775910019874573},{"id":"https://openalex.org/C86554907","wikidata":"https://www.wikidata.org/wiki/Q285613","display_name":"PI3K/AKT/mTOR pathway","level":3,"score":0.5201285481452942},{"id":"https://openalex.org/C2781249067","wikidata":"https://www.wikidata.org/wiki/Q17142288","display_name":"MEK inhibitor","level":4,"score":0.5024008750915527},{"id":"https://openalex.org/C2776087337","wikidata":"https://www.wikidata.org/wiki/Q7448840","display_name":"Selumetinib","level":5,"score":0.48483526706695557},{"id":"https://openalex.org/C57074206","wikidata":"https://www.wikidata.org/wiki/Q14197552","display_name":"MAPK/ERK pathway","level":3,"score":0.47944632172584534},{"id":"https://openalex.org/C42362537","wikidata":"https://www.wikidata.org/wiki/Q87099740","display_name":"Tyrosine kinase","level":3,"score":0.4781968593597412},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.4403606653213501},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4355427622795105},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.4282677173614502},{"id":"https://openalex.org/C2779438470","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"Epidermal growth factor receptor","level":3,"score":0.31064170598983765},{"id":"https://openalex.org/C11960822","wikidata":"https://www.wikidata.org/wiki/Q242736","display_name":"Phosphorylation","level":2,"score":0.2769666016101837},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.26957303285598755},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0909145176410675},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.08065935969352722},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.06372812390327454}],"mesh":[{"descriptor_ui":"D000077156","descriptor_name":"Gefitinib","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001562","descriptor_name":"Benzimidazoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D004789","descriptor_name":"Enzyme Activation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008807","descriptor_name":"Mice, Inbred BALB C","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008819","descriptor_name":"Mice, Nude","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011799","descriptor_name":"Quinazolines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D013274","descriptor_name":"Stomach Neoplasms","qualifier_ui":"Q000201","qualifier_name":"enzymology","is_major_topic":true},{"descriptor_ui":"D013274","descriptor_name":"Stomach Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D020287","descriptor_name":"In Situ Nick-End Labeling","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D034741","descriptor_name":"RNA, Small Interfering","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D048369","descriptor_name":"MAP Kinase Kinase 1","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D048370","descriptor_name":"MAP Kinase Kinase 2","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D051057","descriptor_name":"Proto-Oncogene Proteins c-akt","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D066246","descriptor_name":"ErbB Receptors","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1158/1535-7163.mct-09-0300","doi":"https://doi.org/10.1158/1535-7163.mct-09-0300","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1535-7163.mct-09-0300","pdf_url":null,"source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":"journal-article"},{"id":"pmid:19755509","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19755509","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular cancer therapeutics","raw_type":"Journal Article"},{"id":"pmh:oai:s-space.snu.ac.kr:10371/76384","doi":null,"is_oa":false,"landing_page_url":"https://hdl.handle.net/10371/76384","pdf_url":null,"source":{"id":"https://openalex.org/S4306401345","display_name":"Seoul National University Open Repository (Seoul National University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I139264467","host_organization_name":"Seoul National University","host_organization_lineage":["https://openalex.org/I139264467"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":44,"referenced_works":["https://openalex.org/W44948767","https://openalex.org/W1554963423","https://openalex.org/W1557061959","https://openalex.org/W1964762450","https://openalex.org/W1970424369","https://openalex.org/W2000896073","https://openalex.org/W2002937040","https://openalex.org/W2003984225","https://openalex.org/W2013678879","https://openalex.org/W2014187999","https://openalex.org/W2020995084","https://openalex.org/W2027391918","https://openalex.org/W2032909215","https://openalex.org/W2043696829","https://openalex.org/W2044565900","https://openalex.org/W2049449785","https://openalex.org/W2063665870","https://openalex.org/W2065486105","https://openalex.org/W2065504565","https://openalex.org/W2077309295","https://openalex.org/W2080719056","https://openalex.org/W2100189272","https://openalex.org/W2100626226","https://openalex.org/W2100772783","https://openalex.org/W2101306957","https://openalex.org/W2102088611","https://openalex.org/W2103894337","https://openalex.org/W2114852376","https://openalex.org/W2121389354","https://openalex.org/W2123326378","https://openalex.org/W2123611729","https://openalex.org/W2124301770","https://openalex.org/W2129172946","https://openalex.org/W2129400742","https://openalex.org/W2132630169","https://openalex.org/W2139236349","https://openalex.org/W2140775102","https://openalex.org/W2142799999","https://openalex.org/W2147960762","https://openalex.org/W2152636515","https://openalex.org/W2157016650","https://openalex.org/W2161821474","https://openalex.org/W2164452916","https://openalex.org/W2165859280"],"related_works":["https://openalex.org/W7020192708","https://openalex.org/W2320926732","https://openalex.org/W1920173756","https://openalex.org/W2947357138","https://openalex.org/W2168586185","https://openalex.org/W2143574474","https://openalex.org/W2265601848","https://openalex.org/W1980304753","https://openalex.org/W3127178558","https://openalex.org/W2115199224"],"abstract_inverted_index":{"EGFR":[0,14,30,63,88,106,114,160,200,227,241],"tyrosine":[1,19,49],"kinase":[2,20,50,91],"inhibitors":[3,21,93],"have":[4,22,42,66],"shown":[5,44],"promising":[6],"efficacy":[7],"in":[8,94,172,202,206,210,213],"the":[9,39,55,127,182,195,218,233,238],"treatment":[10,56],"of":[11,57,75,84,112,190,197,235],"tumors":[12,28,61],"with":[13,29,60,138],"mutations":[15,145],"and":[16,89,143,146,167,199,212,240],"amplifications.":[17],"However,":[18,150],"also":[23],"proven":[24],"ineffective":[25],"against":[26,105,225],"most":[27],"wild-type":[31],"(WT)":[32],"alleles.":[33,149],"Although":[34],"some":[35,207],"genetic":[36],"changes,":[37],"including":[38],"KRAS":[40,128,142,147],"mutation,":[41],"been":[43],"to":[45,48,68,79,97,133,156,159],"confer":[46],"resistance":[47],"inhibitors,":[51],"novel":[52,102],"strategies":[53],"for":[54,220],"cancer":[58,117,124],"patients":[59],"harboring":[62,126,141],"WT":[64,107,115,148,228],"alleles":[65],"yet":[67],"be":[69,157],"thoroughly":[70],"delineated.":[71],"The":[72,162],"principal":[73],"objective":[74],"this":[76,191],"study":[77],"was":[78,179],"improve":[80],"our":[81],"current":[82],"understanding":[83,234],"drug":[85],"interactions":[86],"between":[87,237],"MAP/ERK":[90],"(MEK)":[92],"an":[95],"effort":[96],"gain":[98],"insight":[99],"into":[100],"a":[101,110,221],"therapeutic":[103],"strategy":[104,224],"tumors.":[108],"Using":[109],"panel":[111],"human":[113,226],"gastric":[116,123,229],"cell":[118,152,176,208],"lines,":[119,177],"we":[120],"showed":[121,170],"that":[122],"cells":[125,140],"mutation":[129],"were":[130,154],"selectively":[131],"sensitive":[132],"MEK":[134,173,198,239],"inhibition":[135],"as":[136],"compared":[137],"those":[139],"PI3K":[144],"all":[151],"lines":[153,209],"found":[155],"resistant":[158,175],"inhibition.":[161],"results":[163,216],"from":[164],"Western":[165],"blots":[166],"phosphoprotein":[168],"arrays":[169],"that,":[171],"inhibitor":[174],"AKT":[178],"activated":[180],"through":[181,194],"EGFR/HER3/PI3K":[183],"pathway":[184],"following":[185],"AZD6244":[186],"(ARRY-142886)":[187],"treatment.":[188],"Blockade":[189],"feedback":[192],"mechanism":[193],"targeting":[196],"resulted":[201],"detectable":[203],"synergistic":[204],"effects":[205],"vitro":[211],"vivo.":[214],"Our":[215],"provide":[217],"basis":[219],"rational":[222],"combination":[223],"cancers,":[230],"predicated":[231],"on":[232],"cross-talk":[236],"pathways.":[242]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2158971458","counts_by_year":[{"year":2025,"cited_by_count":3},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":1},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":8},{"year":2016,"cited_by_count":6},{"year":2015,"cited_by_count":5},{"year":2014,"cited_by_count":6},{"year":2013,"cited_by_count":9},{"year":2012,"cited_by_count":9}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
